Zobrazeno 1 - 10 of 24 pro vyhledávání: '"Xuebo Zeng"'
1
Akademický článek
Construction and validation of a prognostic model for colon adenocarcinoma based on bile acid metabolism-related genes
Autor: Qinghua Luo, Ping Zhou, Shuangqing Chang, Zhifang Huang, Xuebo Zeng
Publikováno v: Scientific Reports, Vol 13, Iss 1, Pp 1-12 (2023)
Abstract Colon adenocarcinoma (COAD), one of the common clinical cancers, exhibits high morbidity and mortality, and its pathogenesis and treatment are still underdeveloped. Numerous studies have demonstrated the involvement of bile acids in tumour d
Externí odkaz: https://doaj.org/article/ee14980ef101414dadf89e9d08e8cd7e
Zobrazit plný text záznamu
2
Akademický článek
Characterization of butyrate-metabolism in colorectal cancer to guide clinical treatment
Autor: Qinghua Luo, Ping Zhou, Shuangqing Chang, Zhifang Huang, Xuebo Zeng
Publikováno v: Scientific Reports, Vol 13, Iss 1, Pp 1-15 (2023)
Abstract Colorectal cancer (CRC) is the third most prevalent one in the world among the most common malignant tumors. Numerous studies have shown that butyrate has demonstrated promise as an antitumor agent in a variety of human cancer types. However
Externí odkaz: https://doaj.org/article/d5b2dbfb4d50458db09aff9673ae8fb2
Zobrazit plný text záznamu
3
Akademický článek
A Saprophytic Fungus Tubeufia rubra Produces Novel Rubracin D and E Reversing Multidrug Resistance in Cancer Cells.
Autor: Shengyan Qian1,2,3, Xuebo Zeng1,2, Yixin Qian1, Yongzhong Lu4, Zhangjiang He1 zjhe3@gzu.edu.cn, Jichuan Kang1,2 jckang@gzu.edu.cn
Publikováno v: Journal of Fungi. Mar2023, Vol. 9 Issue 3, p1-14. 14p.
Zobrazit plný text záznamu
4
Akademický článek
A Novel Nitrogen-containing Glyceride from Fungal Saprobe Tubeufia rubra Reverses MDR of Tumor Cell Lines to Doxorubicin.
Autor: Xuebo Zeng1,2, Shengyan Qian2,3, Yongzhong Lu4, Yongjie Li2, Lizhuang Chen2, Yixin Qian2, Zhangjiang He2 zjhe3@gzu.edu.cn, Jichuan Kang2 jckang@gzu.edu.cn
Publikováno v: Records of Natural Products. Nov/Dec2022, Vol. 16 Issue 6, p622-632. 11p.
Zobrazit plný text záznamu
5
MarketLine Company Profile: CASI Pharmaceuticals, Inc.
Publikováno v: CASI Pharmaceuticals, Inc. MarketLine Company Profile. 8/6/2024, p1-17. 17p.
Zobrazit plný text záznamu
6
Akademický článek
Construction and validation of a prognostic model for colon adenocarcinoma based on bile acid metabolism-related genes.
Autor: Luo, Qinghua1 (AUTHOR) luohafo2818252021@163.com, Zhou, Ping2 (AUTHOR), Chang, Shuangqing1 (AUTHOR), Huang, Zhifang1 (AUTHOR), Zeng, Xuebo3 (AUTHOR)
Publikováno v: Scientific Reports. 11/18/2023, Vol. 13 Issue 1, p1-12. 12p.
Zobrazit plný text záznamu
7
Akademický článek
Characterization of butyrate-metabolism in colorectal cancer to guide clinical treatment.
Autor: Luo, Qinghua1 (AUTHOR) luohafo2818252021@163.com, Zhou, Ping2 (AUTHOR), Chang, Shuangqing1 (AUTHOR), Huang, Zhifang1 (AUTHOR), Zeng, Xuebo3 (AUTHOR)
Publikováno v: Scientific Reports. 3/29/2023, Vol. 13 Issue 1, p1-15. 15p.
Zobrazit plný text záznamu
8
MarketLine Company Profile: CASI Pharmaceuticals, Inc.
Publikováno v: CASI Pharmaceuticals, Inc. MarketLine Company Profile. 8/2/2023, p1-17. 17p.
Zobrazit plný text záznamu
9
Akademický článek
Smectite formation in metalliferous sediments near the East Pacific Rise at 13°N.
Autor: Rong, Kunbo, Zeng, Zhigang, Yin, Xuebo, Chen, Shuai, Wang, Xiaoyuan, Qi, Haiyan, Ma, Yao
Publikováno v: Acta Oceanologica Sinica; Sep2018, Vol. 37 Issue 9, p67-81, 15p
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje